XASX
SLD
, Last price
AUD
Name
Saluda Medical Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Saluda Medical, Inc., a medical device company, develops treatments for chronic neurological conditions in the United States, Australia, Europe, and internationally. The company offers a closed-loop, dose-control platform which senses and measures neural responses to stimulation and automatically adjusts therapy based on real-time neurophysiological feedback. It provides Evoke, an aid in the management of chronic intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with failed back surgery syndrome, intractable low back pain, and leg pain, and is designed to treat chronic neuropathic pain by providing spinal cord stimulation (SCS) therapy that senses and measures neural activation to optimize therapy and reduce patient and clinician burden. The company was founded in 2011 and is based in Bloomington, Minnesota.
Key people
Kristin Caplice
Executive Officer
Greg Plamondon
Executive Officer
Laureen Debuono
Director
Geoffrey Kinghorn
Director
James Schuermann
Executive Officer, Director
Valuation
No data to show